STOCK TITAN

Nephros Inc Stock Price, News & Analysis

NEPH Nasdaq

Welcome to our dedicated page for Nephros news (Ticker: NEPH), a resource for investors and traders seeking the latest updates and insights on Nephros stock.

Nephros Inc (NEPH) specializes in advanced water purification systems and medical filtration technologies serving healthcare providers and commercial industries. This news hub provides investors and industry professionals with timely updates on operational milestones, product innovations, and strategic initiatives central to the company's mission of enhancing water safety.

Access the latest press releases covering Nephros' developments in hollow fiber filtration technology, regulatory achievements, and market expansions. Our curated collection includes earnings reports, partnership announcements, and updates on medical devices like mid-dilution hemodiafiltration systems designed for chronic renal care.

Key updates focus on advancements in medical water purification and commercial solutions addressing biofilm prevention and waterborne pathogens. Track developments in digital service models and filtration performance enhancements that impact both healthcare outcomes and industrial water management.

Bookmark this page for streamlined access to Nephros' evolving role in water technology. Check regularly for objective reporting on product certifications, executive leadership changes, and clinical trial progress relevant to long-term investors and sector analysts.

Rhea-AI Summary

Nephros (Nasdaq: NEPH) has acquired the assets of GenArraytion, Inc., a leader in infectious disease monitoring. This acquisition aims to enhance Nephros's capabilities in pathogen detection, leveraging GenArraytion’s Polymerase Chain Reaction (PCR) technology to advance their pathogen detection systems. Nephros expects this strategic move to solidify its position in the emerging PCR testing market, improve water safety measures, and provide quicker testing solutions for waterborne pathogens. The integration of technologies is anticipated to enhance customer service through accurate and actionable data.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.87%
Tags
-
Rhea-AI Summary

Nephros, Inc. (NASDAQ: NEPH), a leading water technology company, announced its participation in the Access to Giving Virtual Investor Conference from July 13-15, 2021. CEO Andy Astor will present on July 13th at 2:30 PM ET, with a replay available post-event. The conference will feature over 50 companies focusing on investor education and financial literacy. Nephros aims to advance water safety through innovative solutions. For more details, visit their official site or register for the conference.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.87%
Tags
none
-
Rhea-AI Summary

Nephros, Inc. (Nasdaq: NEPH) reported an anticipated net revenue of approximately $2.2 million for Q2 2021, marking over a 40% year-over-year increase. Year-to-date revenue exceeded $5 million, reflecting a 20% increase compared to the same period in 2020 and 2019. The company also submitted its HDF Assist Module for FDA 510(k) clearance and noted growing revenue in its Pathogen Detection Systems business segment. Nephros ended Q2 with around $8.3 million in cash, positioning itself well for the upcoming months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.82%
Tags
none
Rhea-AI Summary

Nephros, Inc. (Nasdaq: NEPH) reported its highest first-quarter revenue of $2.7 million, an increase of 8% compared to the same period last year. The net loss improved by 55% to $0.5 million, while adjusted EBITDA showed a 13% improvement, totaling ($0.7 million). The company attributes this growth to increased customer acquisition and recurring revenue, as healthcare facilities shift focus from COVID-19 to water management. Nephros had cash and equivalents of $8.2 million as of March 31, 2021, indicating a solid financial position.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.89%
Tags
none
-
Rhea-AI Summary

Nephros, Inc. (Nasdaq: NEPH) announced it will release its first quarter financial results on May 6, 2021, after market close. A conference call is scheduled for the same day at 4:30 PM ET, allowing investors to engage with company executives. Participants can join by calling domestic number 1-844-808-7106 or international number 1-412-317-5285. A replay of the call will be available until May 13, 2021. Nephros specializes in water purification and pathogen detection, focusing on point-of-use water safety.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.15%
Tags
-
Rhea-AI Summary

Nephros, Inc. (Nasdaq: NEPH) has reported a preliminary net revenue of $2.7 million for Q1 2021, marking a 17% increase from the previous quarter and an 8% rise compared to the same period in 2020. This achievement signifies the highest first-quarter revenue in the company's history and the third-highest quarterly revenue overall. The company ended the quarter with approximately $8.1 million in cash. Results are attributed to strong performance across filtration markets despite the pandemic, with expectations for further growth as vaccination progresses.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.63%
Tags
none
Rhea-AI Summary

Nephros, a water technology company specializing in filtration and pathogen detection, announced that CEO Andy Astor will present at the Q1 Virtual Investor Summit from March 23-25, 2021. Nephros's presentation is scheduled for March 23 at 2:30 p.m. ET. Interested participants can register for the event and request one-on-one meetings via the conference's website. Nephros is dedicated to advancing water safety in medical and commercial markets by providing innovative solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.3%
Tags
conferences
-
Rhea-AI Summary

Nephros, a water technology leader, announced that CEO Andy Astor will present at the Inaugural Emerging Growth Virtual Conference on March 17-18, 2021. The event will showcase discussions with C-suite executives and feature insights into Nephros' advancements in water safety, including pathogen detection and purification technologies. The conference aims to connect thousands of issuers with investors through presentations and live Q&A sessions. For more details, visit www.nephros.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.79%
Tags
conferences
-
Rhea-AI Summary

Nephros, Inc. (Nasdaq:NEPH) reported fourth-quarter 2020 net revenue of $2.3 million, a 26% decline from the previous year's $3.2 million. The full-year revenue dropped 17%, totaling $8.6 million compared to $10.3 million in 2019. The net loss for Q4 was approximately ($759,000), marking a significant increase from a net income of $234,000 in 2019. Adjusted EBITDA shows a loss of ($466,000) for Q4, in contrast to a profit of $374,000 a year earlier. Despite challenges due to COVID-19, the company's CEO expressed optimism for a return to growth in the latter half of 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.1%
Tags
Rhea-AI Summary

Nephros, Inc. (Nasdaq: NEPH), a water technology leader, will release its fourth quarter and full year 2020 financial results on March 1, 2021, after market close. A conference call is scheduled for the same day at 4:30 PM ET, where management will discuss the financial results and business outlook. Call-in details include a participant dial-in number and a replay option available until March 8, 2021. Nephros focuses on advancing water safety in medical and commercial sectors through innovative filtration and pathogen detection solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.24%
Tags

FAQ

What is the current stock price of Nephros (NEPH)?

The current stock price of Nephros (NEPH) is $3.78 as of July 14, 2025.

What is the market cap of Nephros (NEPH)?

The market cap of Nephros (NEPH) is approximately 43.2M.
Nephros Inc

Nasdaq:NEPH

NEPH Rankings

NEPH Stock Data

43.25M
9.41M
12.87%
44.7%
0.08%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
SOUTH ORANGE